|
⚲
|
| Keyboard |
| Jambulingam Thani
✚
|
|
|---|---|
| CIK # | 0001818466 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001818466] | |
| 4 | [0001818466] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Virpax Pharmaceuticals Inc | |
| Jambulingam Thani |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Virpax Pharmaceuticals Inc VRPX
Stock Option (right to buy) · derivative
|
2024-01-29 | Grant | 25,000 | $0.00 | |
|
Virpax Pharmaceuticals Inc VRPX
Stock Option (right to buy) · derivative
|
2023-01-01 | Grant | 40,000 | $0.00 | |
|
Virpax Pharmaceuticals Inc VRPX
Stock Option (right to buy) · derivative
|
2022-01-01 | Grant | 14,113 | $0.00 | |
|
Virpax Pharmaceuticals Inc VRPX
Stock Option (right to buy) · derivative
|
2021-04-07 | Grant | 10,205 | $0.00 | |
|
Virpax Pharmaceuticals Inc VRPX
Common Stock, $0.00001 par value
|
2021-02-17 | Buy | 100 | $7.16 | 716 |